Lack of effective tumor-specific delivery systems remains an unmet clinical challenge for successful translation of innovative therapies, such as, therapeutic oligonucleotides. In the past decade, exosomes hav...
from Most Recent Articles: Journal of Nanobiotechnology https://ift.tt/2ObQTyO
via IFTTT
No comments:
Post a Comment